Crossmark

Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years

Crossref DOI link: https://doi.org/10.1016/j.gastrohep.2024.502199

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Esteban, Rafael

Domínguez-Hernández, Raquel

Cantero, Helena

Casado, Miguel Ángel
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-05-07
More Information

This article is maintained by: Elsevier

Article Title: Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years

Journal Title: Gastroenterología y Hepatología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastrohep.2024.502199

Content Type: article

Copyright: © 2024 The Authors. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below